Page last updated: 2024-10-31

neostigmine and Hyperkalemia

neostigmine has been researched along with Hyperkalemia in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neigh, JL1
Stovner, J1
Lund, I1

Reviews

2 reviews available for neostigmine and Hyperkalemia

ArticleYear
Neuromuscular blockade.
    The Surgical clinics of North America, 1975, Volume: 55, Issue:4

    Topics: Anesthesia, Inhalation; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Cholinesterase Inhibitors; Dr

1975
The muscle relaxants and their antagonists.
    British journal of anaesthesia, 1970, Volume: 42, Issue:3

    Topics: Acid-Base Equilibrium; Androstanes; Animals; Anura; Blood Pressure; Carbon Dioxide; Cats; Cholineste

1970